In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").
In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").
In our conversation with Dr. Gorman, we learn about the educational and training resources Fluence is focused on developing to address the growing interest in psychedelic integration and psychedelic-assisted psychotherapy. Dr. Gorman is also kind enough to share his expertise and perspective as it relates to the encouraging results recently released surrounding the Phase 3 Trials testing MDMA-assisted psychotherapy for PTSD conducted by MAPS, and what it potentially means for the future of MDMA-assisted psychotherapy.
*To learn more about the company featured in this episode and the work they’re doing, visit their website: FluenceTraining.com
Israelis and Palestinians Turn to Ayahuasca to Heal Conflict Wounds
